Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NRC HEALTHNRC · Entity 5534 | Director | June 23, 2026 | June 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NRC HEALTH
Report date June 23, 2026 · Filed June 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 40,363 |
Reported balance
After 2026-06-23 transaction · row 1
1 source rowRow 1 · 2026-06-23 · Grant · Acquired 7,697 · Balance 40,363 F1: This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions. |
Filing footnotes · ownership attribution and instrument terms
F1: This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 23, 2026 Filed Jun 25, 2026 20:39 UTC | NRC HEALTH NRC · Entity 5534 | GrantCommon Stock | 7,697 | $0.00 | $0.00 |
DisclosureSEC source: 0001008886-26-000186 · form4.xml · nonDerivative · entry 1 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,363 F1 · shares: This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions. F1 · acquired: This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions. Read SEC document |
| October 17, 2025 Filed Oct 21, 2025 23:20 UTC | NRC HEALTH NRC · Entity 5534 | GrantDirector Stock Option (Right to Buy) · Derivative | 22,625 | $0.00 Strike: $11.61 | $0.00 |
DisclosureSEC source: 0001008886-25-000279 · form4.xml · derivative · entry 1 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,625 Underlying: Common Stock · 22,625 shares Expires 2035-10-17 F1 · security: This award is a grant to the reporting person made under the Issuer's 2025 Omnibus Incentive Plan for participating in two in-person meetings during 2025. Read SEC document |
| May 07, 2025 Filed May 9, 2025 21:08 UTC | NRC HEALTH NRC · Entity 5534 | GrantDirector Stock Option (Right to Buy) · Derivative | 34,917 | $0.00 Strike: $13.09 | $0.00 |
DisclosureSEC source: 0001008886-25-000114 · form4.xml · derivative · entry 1 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,917 Underlying: Common Stock · 34,917 shares Expires 2035-05-07 F1 · derivative.exercise_date: This award is an annual grant to the reporting person made under the Issuer's 2025 Omnibus Incentive Plan on the date of the Issuer's 2025 annual shareholder meeting. The award will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to vesting, forfeiture, and termination provisions. Read SEC document |
| May 08, 2024 Filed May 10, 2024 20:06 UTC | NRC HEALTH NRC · Entity 5534 | GrantDirector Stock Option (Right to Buy) · Derivative | 10,906 | $0.00 Strike: $29.76 | $0.00 |
DisclosureSEC source: 0001008886-24-000146 · form4.xml · derivative · entry 1 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,906 Underlying: Common Stock · 10,906 shares Expires 2034-05-08 F1 · derivative.exercise_date: This award is an annual grant to the reporting person made under the Issuer's 2004 Non-Employee Director Stock Plan (the "Plan") on the date of the Issuer's 2024 annual shareholder meeting. In accordance with the terms of the Plan, the award will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to certain exceptions provided in the Plan. Read SEC document |
| March 27, 2024 Filed Mar 29, 2024 21:07 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 9,259 | $0.00 Strike: $14.95 | $0.00 |
DisclosureSEC source: 0001008886-24-000100 · form4.xml · derivative · entry 3 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,259 shares Expires 2024-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 27, 2024 Filed Mar 29, 2024 21:07 UTC | NRC HEALTH NRC · Entity 5534 | Tax withholdingCommon Stock | 3,487 | $39.70 | $138,433.90 |
DisclosureSEC source: 0001008886-24-000100 · form4.xml · nonDerivative · entry 2 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,666 Read SEC document |
| March 27, 2024 Filed Mar 29, 2024 21:07 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionCommon Stock | 9,259 | $14.95 | $138,422.05 |
DisclosureSEC source: 0001008886-24-000100 · form4.xml · nonDerivative · entry 1 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,153 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2023 Filed May 15, 2023 21:46 UTC | NRC HEALTH NRC · Entity 5534 | GrantDirector Stock Option (Right to Buy) · Derivative | 7,386 | $0.00 Strike: $43.15 | $0.00 |
DisclosureSEC source: 0001008886-23-000066 · form4.xml · derivative · entry 1 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,386 Underlying: Common Stock · 7,386 shares Expires 2033-05-11 F1 · derivative.exercise_date: This award is an annual grant to the reporting person made under the Issuer's 2004 Non-Employee Director Stock Plan (the "Plan") on the date of the Issuer's 2023 annual shareholder meeting. In accordance with the terms of the Plan, the award will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to certain exceptions provided in the Plan. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:54 UTC | NRC HEALTH NRC · Entity 5534 | GrantDirector Stock Option (Right to Buy) · Derivative | 12,078 | $0.00 Strike: $32.46 | $0.00 |
DisclosureSEC source: 0001567619-22-011417 · doc1.xml · derivative · entry 1 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,078 Underlying: Common Stock · 12,078 shares Expires 2032-05-18 F1 · derivative.exercise_date: This award is an annual grant to the reporting person made under the Issuer's 2004 Non-Employee Director Stock Plan (the "Plan") on the date of the Issuer's 2022 annual shareholder meeting. In accordance with the terms of the Plan, the award will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to certain exceptions provided in the Plan. Read SEC document |
| June 29, 2021 Filed Jul 1, 2021 20:51 UTC | NRC HEALTH NRC · Entity 5534 | GrantDirector Stock Option (Right to Buy) · Derivative | 7,289 | $0.00 Strike: $46.32 | $0.00 |
DisclosureSEC source: 0001567619-21-012853 · doc1.xml · derivative · entry 1 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,289 Underlying: Common Stock · 7,289 shares Expires 2031-06-29 F1 · derivative.exercise_date: This award is an annual grant to the reporting person made under the Issuer's 2004 Non-Employee Director Stock Plan (the "Plan") on the date of the Issuer's 2021 annual shareholder meeting. In accordance with the terms of the Plan, the award will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to certain exceptions provided in the Plan. Read SEC document |
| July 23, 2020 Filed Jul 27, 2020 20:43 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 40 | $0.00 Strike: $34.90 | $0.00 |
DisclosureSEC source: 0001567619-20-013765 · doc1.xml · derivative · entry 8 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,400 Underlying: Common Stock · 40 shares Expires 2028-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 23, 2020 Filed Jul 27, 2020 20:43 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 6,821 | $0.00 Strike: $50.62 | $0.00 |
DisclosureSEC source: 0001567619-20-013765 · doc1.xml · derivative · entry 7 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,821 shares Expires 2029-05-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 23, 2020 Filed Jul 27, 2020 20:43 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 5,926 | $0.00 Strike: $9.74 | $0.00 |
DisclosureSEC source: 0001567619-20-013765 · doc1.xml · derivative · entry 6 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,837 Underlying: Common Stock · 5,926 shares Expires 2021-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 23, 2020 Filed Jul 27, 2020 20:43 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 5,926 | $60.10 | $356,163.86 |
DisclosureSEC source: 0001567619-20-013765 · doc1.xml · nonDerivative · entry 5 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,894 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $60.00 to $60.51, inclusive. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within this range. Read SEC document |
| July 23, 2020 Filed Jul 27, 2020 20:43 UTC | NRC HEALTH NRC · Entity 5534 | Tax withholdingCommon Stock | 6,861 | $58.94 | $404,387.34 |
DisclosureSEC source: 0001567619-20-013765 · doc1.xml · nonDerivative · entry 4 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,820 Read SEC document |
| July 23, 2020 Filed Jul 27, 2020 20:43 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionCommon Stock | 40 | $34.90 | $1,396.00 |
DisclosureSEC source: 0001567619-20-013765 · doc1.xml · nonDerivative · entry 3 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,681 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 23, 2020 Filed Jul 27, 2020 20:43 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionCommon Stock | 6,821 | $50.62 | $345,279.02 |
DisclosureSEC source: 0001567619-20-013765 · doc1.xml · nonDerivative · entry 2 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,641 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 23, 2020 Filed Jul 27, 2020 20:43 UTC | NRC HEALTH NRC · Entity 5534 | Exercise / conversionCommon Stock | 5,926 | $9.74 | $57,719.24 |
DisclosureSEC source: 0001567619-20-013765 · doc1.xml · nonDerivative · entry 1 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,820 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2020 Filed May 20, 2020 20:44 UTC | NRC HEALTH NRC · Entity 5534 | GrantDirector Stock Option (Right to Buy) · Derivative | 7,179 | $0.00 Strike: $54.11 | $0.00 |
DisclosureSEC source: 0001567619-20-010828 · doc1.xml · derivative · entry 1 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,179 Underlying: Common Stock · 7,179 shares Expires 2030-05-18 F1 · derivative.exercise_date: This award is an annual grant to the reporting person made under the Issuer's 2004 Non-Employee Director Stock Plan (the "Plan") on the date of the Issuer's 2020 annual shareholder meeting. In accordance with the terms of the Plan, the award will vest and become exercisable on the date immediately preceding the date of the Issuer's next annual shareholder meeting, subject to certain exceptions provided in the Plan. Read SEC document |
| May 29, 2019 Filed Jun 5, 2019 21:49 UTC | NRC HEALTH NRC · Entity 5534 | GrantDirector Stock Option (Right to Buy) · Derivative | 6,821 | $0.00 Strike: $50.62 | $0.00 |
DisclosureSEC source: 0001567619-19-012845 · doc1.xml · derivative · entry 2 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,821 Underlying: Common Stock · 6,821 shares Expires 2029-05-29 Read SEC document |
| May 30, 2018 Filed Jan 22, 2019 23:06 UTC | NRC HEALTH NRC · Entity 5534 | GrantDirector Stock Option (Right to Buy) · Derivative | 10,440 | $0.00 Strike: $34.90 | $0.00 |
DisclosureSEC source: 0001567619-19-001454 · doc1.xml · derivative · entry 2 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,440 Underlying: Common Stock · 10,440 shares Expires 2028-05-30 Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:11 UTC | NRC HEALTH NRCI · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 116 | $0.00 Strike: $14.95 | $0.00 |
DisclosureSEC source: 0001140361-18-025763 · doc1.xml · derivative · entry 5 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,259 Underlying: Common Stock · 116 shares Expires 2024-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:11 UTC | NRC HEALTH NRCI · Entity 5534 | SaleCommon Stock | 2,153 | $34.37 | $74,002.92 |
DisclosureSEC source: 0001140361-18-025763 · doc1.xml · nonDerivative · entry 4 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,894 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 29, 2018. F3 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $34.10 to $34.60. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:11 UTC | NRC HEALTH NRCI · Entity 5534 | SaleCommon Stock | 2,913 | $33.51 | $97,614.63 |
DisclosureSEC source: 0001140361-18-025763 · doc1.xml · nonDerivative · entry 3 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,047 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 29, 2018. F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $33.10 to $34.05. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:11 UTC | NRC HEALTH NRCI · Entity 5534 | Tax withholdingCommon Stock | 50 | $34.55 | $1,727.50 |
DisclosureSEC source: 0001140361-18-025763 · doc1.xml · nonDerivative · entry 2 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,960 Read SEC document |
| May 23, 2018 Filed May 25, 2018 21:11 UTC | NRC HEALTH NRCI · Entity 5534 | Exercise / conversionCommon Stock | 116 | $14.95 | $1,734.20 |
DisclosureSEC source: 0001140361-18-025763 · doc1.xml · nonDerivative · entry 1 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,010 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2018 Filed May 23, 2018 21:21 UTC | NRC HEALTH NRCI · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 10,881 | $0.00 Strike: $14.95 | $0.00 |
DisclosureSEC source: 0001140361-18-025378 · doc1.xml · derivative · entry 8 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,375 Underlying: Common Stock · 10,881 shares Expires 2024-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2018 Filed May 23, 2018 21:21 UTC | NRC HEALTH NRCI · Entity 5534 | SaleCommon Stock | 6,111 | $34.30 | $209,604.24 |
DisclosureSEC source: 0001140361-18-025378 · doc1.xml · nonDerivative · entry 6 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,894 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 29, 2018. F3 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $33.85 to $34.65. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| May 22, 2018 Filed May 23, 2018 21:21 UTC | NRC HEALTH NRCI · Entity 5534 | Tax withholdingCommon Stock | 4,770 | $34.10 | $162,657.00 |
DisclosureSEC source: 0001140361-18-025378 · doc1.xml · nonDerivative · entry 5 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,005 Read SEC document |
| May 22, 2018 Filed May 23, 2018 21:21 UTC | NRC HEALTH NRCI · Entity 5534 | Exercise / conversionCommon Stock | 10,881 | $14.95 | $162,670.95 |
DisclosureSEC source: 0001140361-18-025378 · doc1.xml · nonDerivative · entry 4 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2018 Filed May 23, 2018 21:21 UTC | NRC HEALTH NRCI · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 12,794 | $0.00 Strike: $14.95 | $0.00 |
DisclosureSEC source: 0001140361-18-025378 · doc1.xml · derivative · entry 7 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,256 Underlying: Common Stock · 12,794 shares Expires 2024-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2018 Filed May 23, 2018 21:21 UTC | NRC HEALTH NRCI · Entity 5534 | SaleCommon Stock | 7,290 | $34.66 | $252,691.08 |
DisclosureSEC source: 0001140361-18-025378 · doc1.xml · nonDerivative · entry 3 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,894 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 29, 2018. F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $34.05 to $34.95. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| May 21, 2018 Filed May 23, 2018 21:21 UTC | NRC HEALTH NRCI · Entity 5534 | Tax withholdingCommon Stock | 5,504 | $34.75 | $191,264.00 |
DisclosureSEC source: 0001140361-18-025378 · doc1.xml · nonDerivative · entry 2 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,184 Read SEC document |
| May 21, 2018 Filed May 23, 2018 21:21 UTC | NRC HEALTH NRCI · Entity 5534 | Exercise / conversionCommon Stock | 12,794 | $14.95 | $191,270.30 |
DisclosureSEC source: 0001140361-18-025378 · doc1.xml · nonDerivative · entry 1 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,688 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2018 Filed May 21, 2018 20:30 UTC | NRC HEALTH NRCI · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 2,950 | $0.00 Strike: $14.95 | $0.00 |
DisclosureSEC source: 0001140361-18-024927 · doc1.xml · derivative · entry 15 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,050 Underlying: Common Stock · 2,950 shares Expires 2024-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2018 Filed May 21, 2018 20:30 UTC | NRC HEALTH NRCI · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 10,043 | $0.00 Strike: $16.89 | $0.00 |
DisclosureSEC source: 0001140361-18-024927 · doc1.xml · derivative · entry 14 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,043 shares Expires 2023-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2018 Filed May 21, 2018 20:30 UTC | NRC HEALTH NRCI · Entity 5534 | SaleCommon Stock | 899 | $34.88 | $31,359.01 |
DisclosureSEC source: 0001140361-18-024927 · doc1.xml · nonDerivative · entry 11 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,894 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 29, 2018. F4 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $34.75 to $34.95. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| May 18, 2018 Filed May 21, 2018 20:30 UTC | NRC HEALTH NRCI · Entity 5534 | SaleCommon Stock | 5,900 | $34.44 | $203,217.24 |
DisclosureSEC source: 0001140361-18-024927 · doc1.xml · nonDerivative · entry 10 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,793 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 29, 2018. F3 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $33.7343 to $34.7193. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| May 18, 2018 Filed May 21, 2018 20:30 UTC | NRC HEALTH NRCI · Entity 5534 | Tax withholdingCommon Stock | 1,278 | $34.50 | $44,091.00 |
DisclosureSEC source: 0001140361-18-024927 · doc1.xml · nonDerivative · entry 9 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,693 Read SEC document |
| May 18, 2018 Filed May 21, 2018 20:30 UTC | NRC HEALTH NRCI · Entity 5534 | Exercise / conversionCommon Stock | 2,950 | $14.95 | $44,102.50 |
DisclosureSEC source: 0001140361-18-024927 · doc1.xml · nonDerivative · entry 8 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,971 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2018 Filed May 21, 2018 20:30 UTC | NRC HEALTH NRCI · Entity 5534 | Tax withholdingCommon Stock | 4,916 | $34.50 | $169,602.00 |
DisclosureSEC source: 0001140361-18-024927 · doc1.xml · nonDerivative · entry 7 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,021 Read SEC document |
| May 18, 2018 Filed May 21, 2018 20:30 UTC | NRC HEALTH NRCI · Entity 5534 | Exercise / conversionCommon Stock | 10,043 | $16.89 | $169,626.27 |
DisclosureSEC source: 0001140361-18-024927 · doc1.xml · nonDerivative · entry 6 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,937 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2018 Filed May 21, 2018 20:30 UTC | NRC HEALTH NRCI · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 25,957 | $0.00 Strike: $16.89 | $0.00 |
DisclosureSEC source: 0001140361-18-024927 · doc1.xml · derivative · entry 13 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,043 Underlying: Common Stock · 25,957 shares Expires 2023-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2018 Filed May 21, 2018 20:30 UTC | NRC HEALTH NRCI · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 7,821 | $0.00 Strike: $24.35 | $0.00 |
DisclosureSEC source: 0001140361-18-024927 · doc1.xml · derivative · entry 12 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,821 shares Expires 2027-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2018 Filed May 21, 2018 20:30 UTC | NRC HEALTH NRCI · Entity 5534 | SaleCommon Stock | 24,979 | $34.71 | $866,911.18 |
DisclosureSEC source: 0001140361-18-024927 · doc1.xml · nonDerivative · entry 5 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,894 F1 · kind: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 29, 2018. F2 · price: The price in Column 4 is a weighted average price. The prices actually received ranged from $34.35 to $34.90. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing an average weighted price. Read SEC document |
| May 17, 2018 Filed May 21, 2018 20:30 UTC | NRC HEALTH NRCI · Entity 5534 | Tax withholdingCommon Stock | 12,580 | $34.85 | $438,413.00 |
DisclosureSEC source: 0001140361-18-024927 · doc1.xml · nonDerivative · entry 4 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,873 Read SEC document |
| May 17, 2018 Filed May 21, 2018 20:30 UTC | NRC HEALTH NRCI · Entity 5534 | Exercise / conversionCommon Stock | 25,957 | $16.89 | $438,413.73 |
DisclosureSEC source: 0001140361-18-024927 · doc1.xml · nonDerivative · entry 3 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,453 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2018 Filed May 21, 2018 20:30 UTC | NRC HEALTH NRCI · Entity 5534 | Tax withholdingCommon Stock | 5,464 | $34.85 | $190,420.40 |
DisclosureSEC source: 0001140361-18-024927 · doc1.xml · nonDerivative · entry 2 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,496 Read SEC document |
| May 17, 2018 Filed May 21, 2018 20:30 UTC | NRC HEALTH NRCI · Entity 5534 | Exercise / conversionCommon Stock | 7,821 | $24.35 | $190,441.35 |
DisclosureSEC source: 0001140361-18-024927 · doc1.xml · nonDerivative · entry 1 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,960 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 16, 2018 Filed May 17, 2018 19:26 UTC | NRC HEALTH NRCI · Entity 5534 | Exercise / conversionDirector Stock Option (Right to Buy) · Derivative | 17,483 | $0.00 Strike: $24.35 | $0.00 |
DisclosureSEC source: 0001140361-18-024405 · doc1.xml · derivative · entry 4 NUNNELLY JOHN N · CIK 0001248110 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,821 Underlying: Common Stock · 17,483 shares Expires 2027-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.